The listing below shows our latest News Items and is updated regularly. If you wish to post a news item please select the 'Post News' button on the right. The displayed news feed starts on 1st August 2016. Older items can be found here.
We are pleased to present below all posts archived in 'October, 2016'. If you still can't find what you are looking for, try using the search box.
27 October 2016: Harwell, Oxford, UK - The Electrospinning Company has appointed two new non-executive members to its Board of Directors to help develop its strategy and drive its growing business in the regenerative medical device sector. Drummond Paris and Nigel Edwards join Kate Ronayne (STFC Innovations), Malcolm Chapman (lead angel investor) and Ann Kramer (CEO) as well as observer Mark White (Rainbow Seed Fund).
Read the rest of entry »
25 October 2016: Farnham, UK - How can development teams determine the future value of an asset, with phase 3 data years away? Answering that question requires evaluation of three distinct sources of value: clinical, patient and commercial. Though some consider these value streams independently, the only way to understand how they interact with, and amplify, each other is to review them collectively. Our recommendations on defining the three sources of value, and evaluating them can be found here.
21 October 2016: Abingdon, UK - Genefirst Limited, a molecular diagnostics company working in fields of Infectious Diseases and Personalised medicine reported that it has received ISO 13485:2003 certification for its laboratories based in Abingdon, Oxfordshire.
21 October 2016: Abingdon, UK - Isansys Lifecare, a new generation digital healthcare company, has fought off competition from across the country to be nominated for a prestigious national innovation award which will see the company heading to Parliament later this month. The company has created the Patient Status Engine (PSE), a remarkable new patient monitoring platform which collects and analyses patients’ vital signs and will alert doctors and nurses if a person’s health is deteriorating
20 October 2016: Cardiff, UK – Jellagen Pty Ltd, a medical-technology company is pleased to announce that it was awarded the first Boost Cymru (Wales) award for Life Sciences at an awards dinner held Thursday 6th Oct in Cardiff. Boost Cymru was launched in March 2016 by the Life Sciences Hub Wales, with the aim of encouraging new ideas, products or services from businesses, organisations and individuals from across Wales that could go to market within two years.
The business has been awarded a prize fund worth £50,000 thanks to sponsorship from companies including Microsoft, MSD, Greaves Brewster and GE. The winning package includes support, mentoring and funding as well as the opportunity to travel to the US to take part in a senior leadership training course with internationally renowned speakers.
Jellagen entered the competition to support the product launch of the company’s new hydrogel technology platform as a new 3D cell culture assay ...
20 October 2016: Oxford, UK – Brainomix Ltd, a company developing imaging biomarkers for neurological and cerebrovascular disorders, announced today that it has completed a £1.5 million investment round. This will enable Brainomix to further commercialize its proprietary medical imaging software, e-ASPECTS, and expand its market penetration in Europe, Latin America and the United States. The round was led by Chimera Partners and Parkwalk Advisors with all existing investors participating in the investment round.
19 October 2016: Oxford, UK - Oxford Genetics Ltd, a leading biotech which specialises in DNA design, protein expression optimisation and cell line development technologies and services, has moved its operations to new, state-of-the-art laboratories at The Oxford Science Park.
18 October 2016: Abingdon, UK - AMSBIO announces an extended and updated edition of its popular Organoid Culture Handbook. Launched at the EMBO Symposium on Organoids: Modelling Organ Development and Disease in 3D Culture, the new 24-page handbook includes valuable information about the latest available products, protocols, example results and research paper citations.
17 October, 2016: Oxford, UK & Marlborough, USA - Oxford Immunotec Global PLC a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of under-served immune-regulated conditions, today announced that it plans to release third quarter 2016 financial results prior to market open on Tuesday, November 1, 2016. Dr. Peter Wrighton-Smith, Chief Executive Officer, and Rick Altieri, Chief Financial Officer, will host a conference call to review the Company's results at 8:00 a.m. Eastern Time the same day. The call will be concurrently webcast.
17 October 2016 Boston, USA – The Communications Strategy Group Inc. (CSG), announced today that Victor J. Emmanuel, a senior public relations executive with great depth and strength in the planning of complex marketing communications and crisis management campaigns for private and public sector clients, has joined the firm’s Advisory Board. Further, that Sandra Judd, M.S., a senior marketing and public relations professional with extensive experience in nutritional sciences, healthcare and business-to-business communications, has joined the team as a Senior Consultant.
OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.
Future Blends are looking for an OBN member company who could help them strip solvent from one of their process streams. Initially looking at a 1 tonne scale. If you can help, or know of someone who might be able to then please contact Shane O’Leary at Future Blends. firstname.lastname@example.org.
This is an impromptu noticeboard to let people know about events, other things that are happening, perhaps lab equipment for sale etc. Just drop an email to us, email@example.com, and we will post.